Daniel A Santisteban1, Maite P Mena1, Joan Muir2, Brian E McCabe3, Clara Abalo1, Amanda M Cummings1. 1. Department of Educational and Psychological Studies, School of Education and Human Development, University of Miami. 2. Department of Epidemiology and Public Health, Miller School of Medicine, University of Miami. 3. School of Nursing and Health Studies, University of Miami.
Abstract
OBJECTIVE: The purpose of this randomized trial was to investigate the efficacy of 2 behavioral treatments focusing on different change mechanisms in ameliorating a borderline personality disorder constellation of behaviors and substance use in adolescents referred by juvenile diversion programs. METHODS:Forty adolescents 14-17 years of age and meeting Diagnostic and Statistical Manual of Mental Disorders (4th ed.) criteria for borderline personality disorder and substance use disorders were randomized to integrative borderline personality disorder-oriented adolescent family therapy (I-BAFT) or individual drug counseling. This design allowed a comparison of 2 manualized interventions, 1 family based and 1 individually oriented. Profiles of clinical change were used to detect impact and estimate treatment effect sizes. RESULTS: Primary analyses showed that both interventions had a clinically significant impact on borderline personality disorder behaviors 12 months after baseline but with no differential treatment effects. The impact on substance use was more complex. Subgroup analyses revealed that adolescents with depression had significantly more severe profiles of borderline personality disorder and substance use. These youths were the only group to show reductions in substance use, but they only did so if they received the I-BAFT intervention. Study data also documented the high dosage of intensive residential treatment needed by this population. CONCLUSIONS AND IMPLICATIONS FOR PRACTICE: Results highlight the intensive treatment needs of juvenile justice-involved youths with co-occurring substance use and borderline personality disorder including depression, the hybrid outpatient and residential treatment often required by this population, and the promise of a family-oriented approach, particularly for youths with severe symptoms and co-occurring depression. (PsycINFO Database Record (c) 2015 APA, all rights reserved).
RCT Entities:
OBJECTIVE: The purpose of this randomized trial was to investigate the efficacy of 2 behavioral treatments focusing on different change mechanisms in ameliorating a borderline personality disorder constellation of behaviors and substance use in adolescents referred by juvenile diversion programs. METHODS: Forty adolescents 14-17 years of age and meeting Diagnostic and Statistical Manual of Mental Disorders (4th ed.) criteria for borderline personality disorder and substance use disorders were randomized to integrative borderline personality disorder-oriented adolescent family therapy (I-BAFT) or individual drug counseling. This design allowed a comparison of 2 manualized interventions, 1 family based and 1 individually oriented. Profiles of clinical change were used to detect impact and estimate treatment effect sizes. RESULTS: Primary analyses showed that both interventions had a clinically significant impact on borderline personality disorder behaviors 12 months after baseline but with no differential treatment effects. The impact on substance use was more complex. Subgroup analyses revealed that adolescents with depression had significantly more severe profiles of borderline personality disorder and substance use. These youths were the only group to show reductions in substance use, but they only did so if they received the I-BAFT intervention. Study data also documented the high dosage of intensive residential treatment needed by this population. CONCLUSIONS AND IMPLICATIONS FOR PRACTICE: Results highlight the intensive treatment needs of juvenile justice-involved youths with co-occurring substance use and borderline personality disorder including depression, the hybrid outpatient and residential treatment often required by this population, and the promise of a family-oriented approach, particularly for youths with severe symptoms and co-occurring depression. (PsycINFO Database Record (c) 2015 APA, all rights reserved).
Authors: C P Lucas; H Zhang; P W Fisher; D Shaffer; D A Regier; W E Narrow; K Bourdon; M K Dulcan; G Canino; M Rubio-Stipec; B B Lahey; P Friman Journal: J Am Acad Child Adolesc Psychiatry Date: 2001-04 Impact factor: 8.829
Authors: J S Brook; D W Brook; M De La Rosa; L F Duque; E Rodriguez; I D Montoya; M Whiteman Journal: J Am Acad Child Adolesc Psychiatry Date: 1998-07 Impact factor: 8.829
Authors: Geetha A Subramaniam; Diane Warden; Abu Minhajuddin; Marc J Fishman; Maxine L Stitzer; Bryon Adinoff; Madhukar Trivedi; Roger Weiss; Jennifer Potter; Sabrina A Poole; George E Woody Journal: J Am Acad Child Adolesc Psychiatry Date: 2011-11 Impact factor: 8.829
Authors: Colleen A Halliday-Boykins; Cindy M Schaeffer; Scott W Henggeler; Jason E Chapman; Phillippe B Cunningham; Jeff Randall; Steven B Shapiro Journal: J Subst Abuse Treat Date: 2010-09-09
Authors: Mie Sedoc Jørgensen; Ole Jakob Storebø; Sune Bo; Stig Poulsen; Matthias Gondan; Emma Beck; Andrew M Chanen; Anthony Bateman; Jesper Pedersen; Erik Simonsen Journal: Eur Child Adolesc Psychiatry Date: 2020-05-09 Impact factor: 4.785
Authors: Ole Jakob Storebø; Jutta M Stoffers-Winterling; Birgit A Völlm; Mickey T Kongerslev; Jessica T Mattivi; Mie S Jørgensen; Erlend Faltinsen; Adnan Todorovac; Christian P Sales; Henriette E Callesen; Klaus Lieb; Erik Simonsen Journal: Cochrane Database Syst Rev Date: 2020-05-04
Authors: Mie Sedoc Jørgensen; Ole Jakob Storebø; Jutta M Stoffers-Winterling; Erlend Faltinsen; Adnan Todorovac; Erik Simonsen Journal: PLoS One Date: 2021-01-14 Impact factor: 3.240